{
  "slug": "guardian-bio",
  "name": "Guardian Bio",
  "yc_id": 27263,
  "batch": "Summer 2022",
  "website": "http://www.guardian-bio.com",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:19:42.892129",
    "website": "http://www.guardian-bio.com",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 4687.6,
      "final_url": "https://guardian-bio.com/",
      "redirected": true,
      "checked_at": "2025-10-17T01:19:47.579750"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "guardian-bio.com",
      "registrar": "GoDaddy.com, LLC",
      "creation_date": "2022-06-17T18:20:16",
      "expiration_date": "2026-06-17T18:20:16",
      "domain_age_days": 1217,
      "domain_age_years": 3.3,
      "name_servers": [
        "NS39.DOMAINCONTROL.COM",
        "NS40.DOMAINCONTROL.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": "https://www.linkedin.com/company/guardian-bio",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": true,
      "x_frame_options": false,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 33,
      "server": "DPS/2.0.0+sha-6e30ec3"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:16.558612",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "google/gemini-2.0-flash-001",
    "enriched_at": "2025-10-17T12:42:11.519021",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "Personalized medicine",
        "Immunotherapy advancements",
        "Increased cancer prevalence"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary dendritic cell technology and clinical data.",
      "differentiation": "Dendritic cell-based approach targeting a fundamental immune dysfunction in cancer patients.",
      "competitive_advantages": [
        "Addresses a bottleneck for other therapies",
        "Potential for personalized treatment"
      ],
      "competitive_vulnerabilities": [
        "High development costs",
        "Regulatory hurdles for novel therapies"
      ]
    },
    "business_model": {
      "revenue_model": "Licensing/Partnerships/Direct Sales (Therapeutic)",
      "scalability": "medium",
      "capital_intensity": "high"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Preclinical data",
        "Partnerships with research institutions"
      ],
      "growth_bottlenecks": [
        "Clinical trial success",
        "Securing funding for trials"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "medium",
      "overall_risk_score": 7,
      "key_risks": [
        "Clinical trial failure",
        "Competition from established therapies",
        "Manufacturing complexities"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Novel approach to cancer immunotherapy",
        "Addresses a key immune dysfunction",
        "Large potential market"
      ],
      "concerns": [
        "High regulatory hurdles",
        "Significant capital requirements"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Northwest Biotherapeutics",
        "Immatics"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure seed funding",
        "Advance preclinical studies",
        "Develop strategic partnerships"
      ],
      "expansion_opportunities": [
        "Explore combination therapies",
        "Expand to other cancer types"
      ]
    },
    "tokens_used": {
      "prompt": 709,
      "completion": 561,
      "total": 1270,
      "estimated_cost": 0.000221
    }
  },
  "phase8_complete": true
}